Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine

por Zhou, Shi-Hao, Li, Yu-Ting, Zhang, Ru-Yan, Liu, Yan-Ling, You, Zi-Wei, Bian, Miao-Miao, Wen, Yu, Wang, Jian, Du, Jing-Jing, Guo, Jun
Publicado 2022